Citius Pharmaceuticals, Inc. - FORM 8-K - EX-16 - LETTER FROM M&K CPAS, PLLC - September 17, 2014

Attached files

file filename
8-K - FORM 8-K - Citius Pharmaceuticals, Inc.citius_8k.htm
EX-3.1 - AMENDED AND RESTATED ARTICLES OF INCORPORATION - Citius Pharmaceuticals, Inc.citius_ex31.htm
EX-99.1 - UNAUDITED PRO FORMA CONDENSED FINANCIAL STATEMENTS - Citius Pharmaceuticals, Inc.citius_ex991.htm
EX-10.3 - FORM OF INVESTOR WARRANT - Citius Pharmaceuticals, Inc.citius_ex103.htm
EX-10.1 - FORM OF SUBSCRIPTION AGREEMENT - Citius Pharmaceuticals, Inc.citius_ex101.htm
EX-10.2 - REGISTRATION RIGHTS AGREEMENT - Citius Pharmaceuticals, Inc.citius_ex102.htm
EX-2.1 - SHARE EXCHANGE AND REORGANIZATION AGREEMENT - Citius Pharmaceuticals, Inc.citius_ex21.htm
EXHIBIT 16
 
September 19, 2014
 
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
 
Ladies and Gentlemen:
 
We have read the statements included under Item 4.01 of Form 8-K dated September 12, 2014 of Citius Pharmaceuticals, Inc. (formerly Trail One, Inc.) to be filed with the Securities and Exchange Commission and we agree with such statements insofar as they relate to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.

/s/ M&K CPAS, PLLC                         
M&K CPAS, PLLC
Houston, Texas

Citius Pharmaceuticals, Inc. Reports